Eric S. Daar
Impact in
- Virology top 0.1%
- HIV Research and Treatment
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- HIV/AIDS drug development and treatment 74
- HIV/AIDS Research and Interventions 59
- COVID-19 Clinical Research Studies 33
- SARS-CoV-2 and COVID-19 Research 27
- Virology 90
- HIV Research and Treatment 90
- Co-authors
- David D. Ho (11 shared papers)Tarsem Lal Moudgil (5 shared papers)Susan J. Little (29 shared papers)Richard D. Meyer (2 shared papers)Douglas D. Richman (17 shared papers)Paul Edward Sax (30 shared papers)Ann C. Collier (15 shared papers)Camlin Tierney (21 shared papers)
- Journals
- The Journal of Infectious Diseases (34 papers)Clinical Infectious Diseases (31 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (25 papers)AIDS (19 papers)Journal of Virology (18 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Eric S. Daar
291 papers receiving 14.9k citations
Eric S. Daar's Hit Papers
Peers
Comparison fields: 5 of 148
- Virology 5.1k
- Infectious Diseases 6.6k
- Emergency Medicine 1.4k
- Hepatology 975
- Family Practice 68
Countries citing papers authored by Eric S. Daar
This map shows the geographic impact of Eric S. Daar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Daar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Daar more than expected).
Fields of papers citing papers by Eric S. Daar
This network shows the impact of papers produced by Eric S. Daar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Daar. The network helps show where Eric S. Daar may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric S. Daar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 304 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiretroviral-Drug Resistance among Patients Recently Infected with HIV Hit paper breakdown → | 2002 | 954 |
| 2 | Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection Hit paper breakdown → | 1991 | 705 |
| 3 | Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women Hit paper breakdown → | 2021 | 628 |
| 4 | Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 Hit paper breakdown → | 2011 | 422 |
| 5 | 1990 | 400 | |
| 6 | 2000 | 389 | |
| 7 | 2020 | 329 | |
| 8 | Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial Hit paper breakdown → | 2017 | 314 |
| 9 | 2008 | 310 | |
| 10 | 1997 | 295 | |
| 11 | 2005 | 280 | |
| 12 | 2011 | 279 | |
| 13 | 2011 | 271 | |
| 14 | 1996 | 261 | |
| 15 | 2009 | 253 | |
| 16 | 1991 | 251 | |
| 17 | 2001 | 197 | |
| 18 | 2001 | 171 | |
| 19 | 2016 | 170 | |
| 20 | 2010 | 169 |
About Eric S. Daar
Eric S. Daar is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Hepatology and Epidemiology, having authored 304 papers that have together received 15.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (90 papers), HIV/AIDS drug development and treatment (74 papers), HIV/AIDS Research and Interventions (59 papers), COVID-19 Clinical Research Studies (33 papers), SARS-CoV-2 and COVID-19 Research (27 papers), HIV-related health complications and treatments (21 papers), Hepatitis C virus research (16 papers) and HIV, Drug Use, Sexual Risk (9 papers). The work is most often cited by research in Virology (5.1k citations), Infectious Diseases (6.6k citations), Emergency Medicine (1.4k citations), Hepatology (975 citations) and Family Practice (68 citations). Eric S. Daar has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David D. Ho, Tarsem Lal Moudgil, Susan J. Little, Richard D. Meyer, Douglas D. Richman, Paul Edward Sax, Ann C. Collier, Camlin Tierney, Nasreen C. Jahed and Nicholas S. Hellmann. Their work appears in journals such as The Journal of Infectious Diseases, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.